- US11867687utility2024Methods of BH3 Profiling0 cites
- US11867688utility2024High Throughput BH3 Profiling: a Rapid and Scalable Technology to BH3 Profile on Low Numbers of Cells0 cites
- US11858897utility2024Substituted 6,11-dihydro-5h-benzo[b]carbazoles as Inhibitors of ALK and SRPK0 cites
- US11851472utility2023NKG2D-IG Fusion Protein for Cancer Immunotherapy0 cites
- US11852631utility2023Biomarkers Predictive of Anti-immune Checkpoint Response0 cites
- US11844800utility2023Methods and Compositions for Predicting and Preventing Relapse of Acute Lymphoblastic Leukemia0 cites
- US11845728utility2023Compounds and Methods for Treating Cancer0 cites
- US11845992utility2023Compositions and Methods for Predicting Response and Resistance to CDK4/6 Inhibition0 cites
- US11834520utility2023Selective Targeting of Apoptosis Proteins by Structurally-stabilized And/or Cysteine-reactive NOXA Peptides0 cites
- US11826365utility2023Type II Raf Kinase Inhibitors0 cites
- US11820822utility2023Methods for Sensitizing Cancer Cells to T Cell-mediated Killing by Modulating Molecular Pathways0 cites
- US11814379utility2023Cyano Quinoline Amide Compounds as HER2 Inhibitors and Methods of Use0 cites
- US11815508utility2023Dynamic BH3 Profiling0 cites
- US11807606utility2023Sulfonamide Derivatives for Protein Degradation0 cites
- US11802132utility2023Small Molecules for Inducing Selective Protein Degradation and Uses Thereof0 cites
- US11788151utility2023C-RAF Mutants That Confer Resistance to RAF Inhibitors0 cites
- US11789022utility2023MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors0 cites
- US11789025utility2023Reagents and Methods for Analysis of Proteins and Metabolites Targeted by Covalent Probes0 cites
- US11771697utility2023Small Molecule Degraders of Polybromo-1 (PBRM1)0 cites